Abbott | ABT - Interest Expense On Debt


Abbott reported $297M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Agilent USD 29M 4M Jun/2026
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Boston Scientific USD 100M 4M Sep/2026
Cooper Companies USD 21.5M 600K Jun/2026
Danaher USD 135M 28M Sep/2026
Dexcom USD 3M 100K Jun/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Pfizer USD 667M 4M Jun/2026
Smith & Nephew USD 69M 1000K Dec/2025
Solventum Corp USD 14.24B 146M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Terumo JPY 1.48B 51M Jun/2026
Thermo Fisher Scientific USD 417M 63M Sep/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026